Healthcare & Life Sciences
Passage Bio
United Stateswww.passagebio.com
Passage Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Passage Bio
Passage Bio is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Passage Bio is a clinical-stage gene therapy company developing genetic medicines to treat monogenic neurodegenerative and central nervous system diseases such as frontotemporal dementia and GM1 gangliosidosis.
Explore Passage Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.